Researchers have developed a mathematical model to identify electrical signal patterns in the brain that predict epileptic seizures…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
The first participant has been enrolled in Envision, a natural history study that…
The use of TANGO antisense oligonucleotide-based technology, developed by Stoke Therapeutics, resulted…
The first patient has been enrolled in Epygenix Therapeutics’ multicenter Phase 2 clinical…
Fintepla Reduces Seizure Frequency in Dravet Syndrome Youngsters, Pivotal Phase 3 Trial Reports
Fintepla (fenfluramine) oral solution, developed by Zogenix, significantly reduced seizure…
Activating the SCN1A gene, which is deficient in most patients with Dravet syndrome,…
Use of cannabidiol-based Epidiolex with two anti-epileptic treatments do not appear to raise major…